Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proper definitions of MRI contrast enhancement in liver tumors.

× No keyword cloud information.

12 in total

1. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

Authors: T J Vogl; S Kümmel; R Hammerstingl; M Schellenbeck; G Schumacher; T Balzer; W Schwarz; P K Müller; W O Bechstein; M G Mack; O Söllner; R Felix
Journal: Radiology Date: 1996-07 Impact factor: 11.105

2. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.

Authors: P Reimer; E J Rummeny; H E Daldrup; T Hesse; T Balzer; B Tombach; P E Peters
Journal: Eur Radiol Date: 1997 Impact factor: 5.315

3. Contrast enhancement with Gd-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide.

Authors: M Fujita; R Yamamoto; B Fritz-Zieroth; T Yamanaka; M Takahashi; T Miyazawa; M Tatsuta; N Terada; N Hosomi; E Inoue; C Kuroda
Journal: J Magn Reson Imaging Date: 1996 May-Jun Impact factor: 4.813

4. Paradoxic uptake of Gd-EOB-DTPA by hepatocellular carcinoma in mice: quantitative image analysis.

Authors: M Fujita; R Yamamoto; M Takahashi; T Tsuji; T Yamanaka; T Miyazawa; B Fritz-Zieroth; N Terada; C Kuroda
Journal: J Magn Reson Imaging Date: 1997 Jul-Aug Impact factor: 4.813

5. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments.

Authors: Y Ni; G Marchal
Journal: Top Magn Reson Imaging Date: 1998-06

6. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Authors: Christoph J Zech; Luigi Grazioli; Josy Breuer; Maximilian F Reiser; Stefan O Schoenberg
Journal: Invest Radiol Date: 2008-07 Impact factor: 6.016

7. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.

Authors: Masato Narita; Etsuro Hatano; Shigeki Arizono; Aya Miyagawa-Hayashino; Hiroyoshi Isoda; Koji Kitamura; Kojiro Taura; Kentaro Yasuchika; Takashi Nitta; Iwao Ikai; Shinji Uemoto
Journal: J Gastroenterol Date: 2009-04-29 Impact factor: 7.527

8. Tumor models and specific contrast agents for small animal imaging in oncology.

Authors: Yicheng Ni; Huaijun Wang; Feng Chen; Junjie Li; Frederik DeKeyzer; Yuanbo Feng; Jie Yu; Hilde Bosmans; Guy Marchal
Journal: Methods Date: 2009-03-26 Impact factor: 3.608

9. Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization.

Authors: Y Ni; G Marchal; J Yu; A Mühler; G Lukito; A L Baert
Journal: J Magn Reson Imaging Date: 1994 May-Jun Impact factor: 4.813

Proper definitions of MRI contrast enhancement in liver tumors.